News

FDA predicts opioid stacking may occur because of the acute pain treatment.

New cohort analysis shows patients with ulcerative colitis or Crohn's disease who have received invasive care may be affected long-term.

Dr. Kliger discusses how nephrologists can safely treat patients this winter.

NASH and NAFLD are notoriously difficult to treat conditions.

Two-thirds of all excess deaths this year have been directly driven by the pandemic, according to findings.

Cataracts, but not AMD or glaucoma, were associated with an increased risk of depressive symptoms in the elderly in a prospective long-term study.

An expert offers 5 tips to physicians and patients on best practices for managing symptoms related to allergic asthma.

The schizophrenia drug currently has a PDUFA date set for November 15.

The Arbor Pharmaceutical drug is aimed at treating ADHD without being manipulated for non-oral use.

New findings from the Congo highlight risks both mothers and their children face in delivery.

About 69% of patients with CIU were either obese or overweight, and experienced a longer duration of disease than those who had lower weight values.

TLR9 activation shows potential as a target for ulcerative colitis and warrants further testing.

The investigators also found the effects of dapagliflozin were similar in patients with type 2 diabetes and those without type 2 diabetes.

There was also a decline depression care in recent years among adolescents and young adults.

The new dermatology podcast series will launch this month and will be hosted by dermatologist and professor Dr. Brad Glick.

Although sickle cell disease is the most common inherited blood disorder in the US, there are still knowledge and prioritization gaps that need to be addressed.

A virtual reality platform could enable ADHD patients to improve cognitive functioning.

New research suggests the Janus kinase 1 and 2 inhibitor relieves symptoms of atopic dermatitis at a daily dose of 4 mg.

Newly published data show routine testing is unlikely to change the management of patients with CSU.

Paul Christo, MD, discusses opioid addiction during the pandemic, the role of the clinician, and offers a hopeful outlook for the future.

Experts expect an increase in mental health issues caused by the pandemic in the future.

Cytokinetics announces presentations on two trials assessing omecamtiv mecarbil in patients with heart failure and reduced ejection fraction.

The Digihaler is a digital inhaler aimed at improving inhaler techniques.

Medication might be best used as a first-line option for patients with ADHD.

An expert discusses trends in pediatric mental health and receipt of treatment.

Dr. Fauci gives perspective on the future presence of the virus, improving US pandemic preparedness, and the theological divisions which have plagued national response.

Researchers suggest avoiding cow’s milk formula for newborns in the first 3 days of life.

Nephrologists have used telemedicine tools to help treat patients during the pandemic.